Similar articles

• [Long-term treatment with interferon-alpha can induce sarcoidosis. The connection can be stronger than earlier believed].

  Grunewald J, Andersson O, Berlin M, Bradley M, Zetterberg G, Weiland O, Eklund A. Grunewald J, et al. Lakartidningen. 2006 Jun 28-Jul 11;103(26-27):2045-8. Lakartidningen. 2006. PMID: 16881277 Swedish. No abstract available.
• [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].

  Honsová E, Sticová E, Sperl J. Honsová E, et al. Cesk Patol. 2007 Jan;43(1):27-30. Cesk Patol. 2007. PMID: 17370474 Czech.
• Interferon plus ribavirin: a cautionary note.

  Macedo G, Ribeiro T. Macedo G, et al. Am J Gastroenterol. 1999 Oct;94(10):3087-8. doi: 10.1111/j.1572-0241.1999.03087.x. Am J Gastroenterol. 1999. PMID: 10520894 No abstract available.
• Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature.

  López V, Molina I, Monteagudo C, Jordá E. López V, et al. Int J Dermatol. 2011 Mar;50(3):287-91. doi: 10.1111/j.1365-4632.2010.04728.x. Int J Dermatol. 2011. PMID: 21342161 Review.
• [Treatment of chronic hepatitis C: side effects, tolerability and quality of life].

  Gournay J, Richou C. Gournay J, et al. Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B60-75. Gastroenterol Clin Biol. 2002. PMID: 12180310 Review. French. No abstract available.